GlassScriptPhysician profile
Andrea Gentile
NPI 1942664784
$16,451.62
in general payments reported to CMS, 2019-2025
23 companies · $5,675 in 2025
The $5,675 reported for 2025 was more than what 96% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $537 · 2022: $3,848 · 2023: $1,605 · 2024: $4,787 · 2025: $5,675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,902 · Travel and Lodging: $2,164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,902.28 |
| Travel and Lodging | $2,164.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $9,816.60 | 2021-2025 | Inspire |
| Stryker Corporation | $1,399.30 | 2021-2024 | Scopis Ent, Audion Et Dilation System |
| Medical Device Business Services, INC. | $1,260.79 | 2022 | |
| Spirair, INC. | $1,166.29 | 2024-2025 | Septalign |
| Aerin Medical INC. | $808.35 | 2022-2025 | |
| Smith+Nephew, INC. | $731.40 | 2021-2025 | Halo, Rf20000 |
| Medtronic, INC. | $236.12 | 2023-2025 | Propel, Sinuva, Nuvent |
| Acclarent, INC | $198.13 | 2021-2023 | Trudi Nav Cable, Relieva Spinplus |
| Neurent Medical Limited | $147.52 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Glaxosmithkline, LLC. | $118.20 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $113.36 | 2021-2025 | Dupixent |
| Intersect Ent, INC. | $112.38 | 2021 | |
| Genzyme Corporation | $75.68 | 2024 | |
| Integra Lifesciences Corporation | $59.50 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Xoran Technologies LLC | $55.08 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $28.00 | 2025 | Vistaseal, Ethicon |
| Acelrx Pharmaceuticals, INC. | $22.03 | 2022 | |
| Lilly USA, LLC | $19.61 | 2025 | Zepbound |
| Karl Storz Endoscopy-America | $18.76 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.51 | 2025 | |
| Bolder Surgical, LLC | $18.43 | 2022 | |
| Alk-Abello, INC | $15.30 | 2025 | Pre-Pen |
| Olympus America INC. | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Gentile listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.